1Finoux AL, Chartrand P. Oncogenic and tumour suppressor microR NAs[J]. Med Sci (Paris), 2008, 24(12) : 1049-1054.
2Nelson K M, Weiss G J. MicroRNAs and cancer: past, present, and potential future[J]. Mol Cancer Ther, 2008, 7(12), 3655-3660.
3Fujita S, Iba H. Gene regulatory network involving miRNA[J]. Tanpakushitsu Kakusan Koso, 2008, 53(13)~ 1781-1786.
4DErrico M, Lemma T, Calcagnile A, etal. Cell type and DNA dam age specific response of human skin cells to environmental agents[J]. Murat Res, 2007, 614(1-2) : 37-47.
3Girard PM, Pozzebon M, Delacote F, et al. Inhibition of S-phase progression triggered by UVA-induced ROS does not require a functional DNA damage checkpoint response in mammalian cells [J]. DNA Repair (Amst), 2008, 7(9): 1500-16.
4Branzei D, Foiani M. Regulation of DNA repair throughout the cell cycle[J]. Nat Rev Mol Cell Biol, 2008, 9(4): 297-308.
5Naugler WE and Karin M, NF-kappaB and cancer-identifying targets and mechanisms [J]. Curr Opin Genet Dev, 2008, 18(1): 19-26.
6Edwards MR, Bartlett NW, Clarke D, et al. Targeting the NF- kappaB pathway in asthma and chronic obstructive pulmonary disease[J]. Pharmacol Ther, 2009, 121(1): 1-13.
7Gagliardo R, Chanez P, Mathieu M, et al. Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma[J]. Am J Respir Crit Care Med, 2003, 168(10): 1190-8.
8Campbell KJ, Rocha S, Perkins ND. Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B [J]. Mol Cell, 2004, 13(6): 853-65.
